Merck (MRK)
$87.81
1.21 (1.38%)
MRK Stock Quote Delayed 30 Minutes
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$87.12
Market Cap
218.75B
PE Ratio
13.04
EPS
6.7363
Volume (Avg. Vol.)
10.56M
Day's Range
$85.32 - $87.07
52-Week Range
$80.37 - $131.60
Dividend & Yield
$3.16 (3.60%)
MRK Stock Predictions, Articles, and Merck News
3 Biotech Stocks to Buy in Case of Another Pandemic
These are three of the best biotech stocks to keep an eye on as the industry helps governments prepare for the next pandemic.
7 Healthcare Stocks to Buy for Positive Inflation-Adjusted Returns
These are the healthcare stocks to buy as they represent companies with good fundamentals, stable growth visibility and cash flow upside.
3 Undervalued Blue-Chip Stocks Ready for a Big Comeback
Uncover top picks in undervalued blue-chip stocks, unfairly punished yet consistently delivering strong operational results
Beat the CPI: 7 Blue-Chip Stocks Growing Faster Than Inflation
These are the blue-chip stocks to buy as they represent fundamentally strong companies with robust free cash flow visibility
7 Quiet Blue-Chip Stocks on the Verge of a Big Breakout Rally
These are the undervalued blue-chip stocks to buy as they represent companies with a steady growth and robust cash flow outlook.
3 Undervalued Pharma Stocks to Buy for Dividends and Capital Gains
These are the undervalued pharma stocks and represent companies with a deep research pipeline, that provides sustained growth visibility.
3 High-Yield Dividend Stocks to Collect Impressive Payouts Year After Year
High-yield dividend stocks can be resilient performers in long-term portfolios and provide steady income and robust growth in June.
MRK Stock Earnings: Merck & Co Beats EPS, Beats Revenue for Q1 2024
MRK stock results show that Merck & Co beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
